![Johannes Nippgen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Johannes Nippgen worked as the Chief Medical Officer at Alphamab Oncology from 2021 to 2022.
He holds a doctorate degree from The Johannes Gutenberg University of Mainz and Julius-Maximilians-Universität Würzburg.
Former positions of Johannes Nippgen
| Companies | Position | End |
|---|---|---|
| ALPHAMAB ONCOLOGY | Chief Tech/Sci/R&D Officer | 2022-01-31 |
Training of Johannes Nippgen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alphamab Oncology
 Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Johannes Nippgen
